AstraZeneca
AZN
#61
Rank
C$387.79 B
Marketcap
C$250.05
Share price
0.81%
Change (1 day)
25.03%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): C$9.68

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$9.72. In 2024 the company made an earnings per share (EPS) of C$6.35 an increase over its 2023 EPS that were of C$5.37.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$9.68
2024C$6.3518.23%
2023C$5.3781.13%
2022C$2.97631.03%
2021C$0.41-88.11%
2020C$3.41136.89%
2019C$1.44-39.41%
2018C$2.38-28.27%
2017C$3.32-14.37%
2016C$3.8724.11%
2015C$3.12127.55%
2014C$1.37-51.96%
2013C$2.85-58.95%
2012C$6.95-32.2%
2011C$10.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.22 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.82 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.83-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.05-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.49 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.58-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$13.08 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.98-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.98-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.44-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK